Late-stage specialty pharmaceutical company iX Biopharma Ltd’s initial public offering (IPO) has seen a strong response from institutional and retail investors. The company’s public offer was nearly 24 times oversubscribed.Its shares will begin trading at 9 am Wednesday.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
